NIFTY 50

Exclusive | As India faces shortage of remdesivir, Cipla says its supplies will hit market in next 1-2 days

Updated : July 08, 2020 01:18 PM IST

Cipla has contracted the manufacturing of remdesivir to Mumbai-based BDR Pharma that also makes the active pharmaceutical ingredient (API) for the drug.

You May Also Like

Live TV

recommended for you